☰

Inna Gaisler-Salomon - Publications

Affiliations: 
Columbia University, New York, NY 
Area:
Glutamate in Schizophrenia: Animal Models
Tree Info Grants Similar researchers PubMed Report error

30 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Wan C, Xia Y, Yan J, Lin W, Yao L, Zhang M, Gaisler-Salomon I, Mei L, Yin DM, Chen Y. nNOS in Erbb4-positive neurons regulates GABAergic transmission in mouse hippocampus. Cell Death & Disease. 15: 167. PMID 38396027 DOI: 10.1038/s41419-024-06557-1  0.309
2023 Asraf K, Zaidan H, Natoor B, Gaisler-Salomon I. Synergistic, long-term effects of glutamate dehydrogenase 1 deficiency and mild stress on cognitive function and mPFC gene and miRNA expression. Translational Psychiatry. 13: 248. PMID 37419882 DOI: 10.1038/s41398-023-02534-y  0.332
2022 Bauminger H, Gaisler-Salomon I. Beyond NMDA Receptors: Homeostasis at the Glutamate Tripartite Synapse and Its Contributions to Cognitive Dysfunction in Schizophrenia. International Journal of Molecular Sciences. 23. PMID 35955750 DOI: 10.3390/ijms23158617  0.311
2022 Bauminger H, Zaidan H, Akirav I, Gaisler-Salomon I. Anandamide Hydrolysis Inhibition Reverses the Long-Term Behavioral and Gene Expression Alterations Induced by MK-801 in Male Rats: Differential CB1 and CB2 Receptor-Mediated Effects. Schizophrenia Bulletin. PMID 35092675 DOI: 10.1093/schbul/sbab153  0.323
2021 Merlin J, Ivanov S, Dumont A, Sergushichev A, Gall J, Stunault M, Ayrault M, Vaillant N, Castiglione A, Swain A, Orange F, Gallerand A, Berton T, Martin JC, Carobbio S, ... ... Gaisler-Salomon I, et al. Non-canonical glutamine transamination sustains efferocytosis by coupling redox buffering to oxidative phosphorylation. Nature Metabolism. 3: 1313-1326. PMID 34650273 DOI: 10.1038/s42255-021-00471-y  0.559
2019 Gaisler-Salomon I, Lander SS, Chakraborty D, Asraf K, Safory H, Wolosker H, Kaphzan H. 21.3 NEURONAL-ASTROCYTIC REGULATION OF GLUTAMATE HOMEOSTASIS: RELEVANCE TO COGNITIVE DYSFUNCTION IN SCHIZOPHRENIA Schizophrenia Bulletin. 45: S124-S124. DOI: 10.1093/Schbul/Sbz022.087  0.459
2019 Gaisler-Salomon I. 21. The Tripartite Synapse: The Role Of Neuron-Astrocyte Interactions In Schizophrenia Psychopathology Schizophrenia Bulletin. 45. DOI: 10.1093/Schbul/Sbz022.084  0.432
2018 Lander SS, Khan U, Lewandowski N, Chakraborty D, Provenzano FA, Mingote S, Chornyy S, Frigerio F, Maechler P, Kaphzan H, Small SA, Rayport S, Gaisler-Salomon I. Glutamate Dehydrogenase-Deficient Mice Display Schizophrenia-Like Behavioral Abnormalities and CA1-Specific Hippocampal Dysfunction. Schizophrenia Bulletin. PMID 29471549 DOI: 10.1093/Schbul/Sby011  0.696
2018 Heffetz-Giterman L, Lander SS, Cohen R, Gross A, Gaisler-Salomon I. T220. The Glutaminase Inhibitor Ebselen Prevents Amphetamine Sensitization In Mice Schizophrenia Bulletin. 44. DOI: 10.1093/Schbul/Sby016.496  0.485
2017 Mingote S, Chuhma N, Kalmbach A, Thomsen GM, Wang Y, Mihali A, Sferrazza CE, Zucker-Scharff I, Siena AC, Welch MG, Lizardi-Ortiz J, Sulzer D, Moore H, Gaisler-Salomon I, Rayport S. Dopamine neuron dependent behaviorsmediated by glutamate cotransmission. Elife. 6. PMID 28703706 DOI: 10.7554/Elife.27566  0.738
2017 Mingote S, Chuhma N, Kalmbach A, Thomsen GM, Wang Y, Mihali A, Sferrazza C, Zucker-Scharff I, Siena A, Welch MG, Lizardi-Ortiz J, Sulzer D, Moore H, Gaisler-Salomon I, Rayport S. Author response: Dopamine neuron dependent behaviors mediated by glutamate cotransmission Elife. DOI: 10.7554/Elife.27566.036  0.711
2017 Lander SS, Chakraborti D, Donner R, Provenzano F, Lewandowski N, Mingote SM, Maechler P, Rayport S, Small SA, Kaphzan H, Gaisler-Salomon I. 216. Glutamate Dehydrogenase-Deficient Mice: A Novel Mouse Model of Schizophrenia-Like Phenotypes Schizophrenia Bulletin. 43: S109-S110. DOI: 10.1093/Schbul/Sbx021.294  0.705
2016 Lander SS, Linder-Shacham D, Gaisler-Salomon I. Differential effects of social isolation in adolescent and adult mice on behavior and cortical gene expression. Behavioural Brain Research. 316: 245-254. PMID 27618762 DOI: 10.1016/j.bbr.2016.09.005  0.322
2016 Mitchell AC, Javidfar B, Bicks LK, Neve R, Garbett K, Lander SS, Mirnics K, Morishita H, Wood MA, Jiang Y, Gaisler-Salomon I, Akbarian S. Longitudinal assessment of neuronal 3D genomes in mouse prefrontal cortex. Nature Communications. 7: 12743. PMID 27597321 DOI: 10.1038/Ncomms12743  0.356
2015 Mingote S, Masson J, Gellman C, Thomsen GM, Lin CS, Merker RJ, Gaisler-Salomon I, Wang Y, Ernst R, Hen R, Rayport S. Genetic Pharmacotherapy as an Early CNS Drug Development Strategy: Testing Glutaminase Inhibition for Schizophrenia Treatment in Adult Mice. Frontiers in Systems Neuroscience. 9: 165. PMID 26778975 DOI: 10.3389/Fnsys.2015.00165  0.7
2015 Brande-Eilat N, Golumbic YN, Zaidan H, Gaisler-Salomon I. Acquisition of conditioned fear is followed by region-specific changes in RNA editing of glutamate receptors. Stress (Amsterdam, Netherlands). 18: 309-18. PMID 26383032 DOI: 10.3109/10253890.2015.1073254  0.301
2014 Hazan L, Gaisler-Salomon I. Glutaminase1 heterozygous mice show enhanced trace fear conditioning and Arc/Arg3.1 expression in hippocampus and cingulate cortex. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 24: 1916-24. PMID 25453483 DOI: 10.1016/j.euroneuro.2014.10.003  0.407
2014 Bock J, Poeschel J, Schindler J, Börner F, Shachar-Dadon A, Ferdman N, Gaisler-Salomon I, Leshem M, Braun K, Poeggel G. Transgenerational sex-specific impact of preconception stress on the development of dendritic spines and dendritic length in the medial prefrontal cortex. Brain Structure & Function. PMID 25395153 DOI: 10.1007/S00429-014-0940-4  0.305
2013 Kravitz E, Gaisler-Salomon I, Biegon A. Hippocampal glutamate NMDA receptor loss tracks progression in Alzheimer's disease: quantitative autoradiography in postmortem human brain. Plos One. 8: e81244. PMID 24312282 DOI: 10.1371/journal.pone.0081244  0.337
2012 Mihali A, Subramani S, Kaunitz G, Rayport S, Gaisler-Salomon I. Modeling resilience to schizophrenia in genetically modified mice: a novel approach to drug discovery. Expert Review of Neurotherapeutics. 12: 785-99. PMID 22853787 DOI: 10.1586/Ern.12.60  0.674
2012 Gaisler-Salomon I, Wang Y, Chuhma N, Zhang H, Golumbic YN, Mihali A, Arancio O, Sibille E, Rayport S. Synaptic underpinnings of altered hippocampal function in glutaminase-deficient mice during maturation. Hippocampus. 22: 1027-39. PMID 22431402 DOI: 10.1002/Hipo.22014  0.681
2011 Gellman C, Mingote S, Wang Y, Gaisler-Salomon I, Rayport S. Genetic pharmacotherapy: A new approach to drug development for schizophrenia F1000research. 2. DOI: 10.7490/F1000Research.949.1  0.641
2010 Gaisler-Salomon I, Wang Y, McKinney SM, Ramsey AJ, Sibille E, Rayport S. ADULT-ONSET GLUTAMATE RECEPTOR EXPRESSION DEFICITS IN THE HIPPOCAMPUS OF GLUTAMINASE-DEFICIENT MICE Schizophrenia Research. 117: 389. DOI: 10.1016/j.schres.2010.02.701  0.66
2010 Moghaddam B, Gaisler-Salomon I, O′Donnell P, Sawa A, Sokoloff P, Uhlhaas P. MAKING CONNECTIONS: ABNORMAL WHITE MATTER DEVELOPMENT IN THE EARLY STAGES OF SCHIZOPHRENIA Schizophrenia Research. 117: 110. DOI: 10.1016/J.Schres.2010.02.026  0.355
2009 Gaisler-Salomon I, Schobel SA, Small SA, Rayport S. How high-resolution basal-state functional imaging can guide the development of new pharmacotherapies for schizophrenia. Schizophrenia Bulletin. 35: 1037-44. PMID 19828591 DOI: 10.1093/Schbul/Sbp114  0.681
2009 Gaisler-Salomon I, Miller GM, Chuhma N, Lee S, Zhang H, Ghoddoussi F, Lewandowski N, Fairhurst S, Wang Y, Conjard-Duplany A, Masson J, Balsam P, Hen R, Arancio O, Galloway MP, et al. Glutaminase-deficient mice display hippocampal hypoactivity, insensitivity to pro-psychotic drugs and potentiated latent inhibition: relevance to schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 34: 2305-22. PMID 19516252 DOI: 10.1038/Npp.2009.58  0.771
2008 Gaisler-Salomon I, Diamant L, Rubin C, Weiner I. Abnormally persistent latent inhibition induced by MK801 is reversed by risperidone and by positive modulators of NMDA receptor function: differential efficacy depending on the stage of the task at which they are administered. Psychopharmacology. 196: 255-67. PMID 17928997 DOI: 10.1007/s00213-007-0960-3  0.587
2003 Weiner I, Schiller D, Gaisler-Salomon I, Green A, Joel D. A comparison of drug effects in latent inhibition and the forced swim test differentiates between the typical antipsychotic haloperidol, the atypical antipsychotics clozapine and olanzapine, and the antidepressants imipramine and paroxetine. Behavioural Pharmacology. 14: 215-22. PMID 12799523 DOI: 10.1097/01.fbp.0000069579.37661.63  0.684
2003 Weiner I, Schiller D, Gaisler-Salomon I. Disruption and potentiation of latent inhibition by risperidone: the latent inhibition model of atypical antipsychotic action. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 28: 499-509. PMID 12629529 DOI: 10.1038/sj.npp.1300069  0.621
2003 Gaisler-Salomon I, Weiner I. Systemic administration of MK-801 produces an abnormally persistent latent inhibition which is reversed by clozapine but not haloperidol. Psychopharmacology. 166: 333-42. PMID 12599023 DOI: 10.1007/s00213-002-1311-z  0.608
Show low-probability matches.